Spire Healthcare Group could start a technical downturn after the rebound of recent sessions.

The firm’s poor Surperformance rating underlines the weak finances, the unattractive valuation and the bad EPS estimates revisions.

After a substantial upturn, the stock now approaches the GBp 386/390 resistance area. This zone has proved its relevance in the long and in the medium term, and could inverse the tendency. In addition, a high RSI indicator should entice a marked fall close to the short term GBp 348 support.

The upside seems limited as shown by fundamentals and technical configuration. In contact with the GBp 390 resistance, a movement of consolidation could return the stock towards the GBp 348 mid-term support. As a result, the most aggressive investors could take a short position now and set a stop loss above this resistance because the crossing of this level would invalidate our scenario.